The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset

Nicola Antonio Adolfo Quaranta, Antonio Daniele, Giancarlo Logroscino

Risultato della ricerca: Contributo in rivistaArticolo in rivista

15 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science